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MEDICAL APPLICATIONS OF ARTIFICIAL 
OLFACTOMETRY 
CROSS-REFERENCES TO RELATED 
APPLICATIONS 
This application claims priority to U.S. Provisional Appli- 
cations Ser. No. 601090,012, filed Jun. 19,1998, and Ser. No. 
601091,179, filed Jun. 30,1998, the disclosures of which are 
incorporated herein by reference in their entirety. 
STATEMENT AS TO RIGHTS TO INVENTIONS 
MADE UNDER FEDERALLY SPONSORED 
RESEARCH AND DEVELOPMENT 
The research carried out in the subject application was 
sponsored, in part, by grants from: ARO (DAAG-55-97-1- 
0187); DARPA (DAAK60-97-K-9503); and NASA (49- 
244-30002-0-8280), and is subject to the provisions of 
Public Law 96-517 (35 U.S.C. 5 202). The government may 
have certain rights in any patents issuing on this application. 
BACKGROUND OF THE INVENTION 
An artificial olfactory system is a device that is capable of 
detecting a wide variety of analytes in fluids such as vapors, 
gases and liquids. The device comprises an array of sensors 
that in the presence of an analyte produces a response. The 
device produces a unique signature output for a particular 
analyte. Using pattern recognition algorithms, the output 
signature, such as an electrical response, can be correlated 
and compared to a particular analyte or mixture of sub- 
stances that are known. By comparing the unknown signa- 
ture with the stored or known signatures, the analyte can be 
detected, identified and quantified. 
There are many instances where it is desirable to measure 
trace amounts of analytes. However, in certain instances, the 
analytes are found at levels that are too low to register a 
robust signal by direct exposure to currently available sen- 
sors. In headspace analysis of applications in agricultural, 
wine, tobacco, perfume, plastics, and the food industries, the 
detection and classification of trace levels of gases are 
present in the sub part per million (ppm) range, making 
detection difficult. Moreover, in residue analysis of pesti- 
cides on crops, the trace levels of certain herbicides must 
meet federal guidelines. For certain crops, these residues are 
present on the crops in the part per billion levels (ppb). 
Another potential application wherein the detection of 
trace levels of analytes is important is the diagnosis of 
patients’ conditions from an analysis of their breath. Marker 
gases such as hydrogen sulfide and methyl mercaptan, which 
are important in diagnosing the presence of oral or lung 
conditions from the breath of human patients, often exist in 
concentrations of 0.01-1 parts per million (or lower). 
However, the threshold detection levels of currently known 
sensors are in the range of 1-100 parts per million. 
Currently, the most widely used device for detecting oral 
malodors is the Halimeter, which is commercially available 
from Interscan Corp. (Chatsworth, Calif.). Using an elec- 
trochemical cell that is sensitive to volatile sulfur com- 
pounds (VSC), the device can oxidize the VSC at the anode 
according to the following reactions: 
H2S-S+2Hf+2e- 
2CH3SH-CH3S-S4H3+S+2Hf+2e- 
C H 3 S 4 H 3 + 2 H 2 0  -2CH30H+S+2Hf+2e 
However, one obvious drawback is that the Halimeter 
cannot distinguish between volatile sulfur compounds. 
2 
Similarly, other volatile substances can interfere with the 
readings of the VSC. 
A second device for the detection of breath and odors 
associated therewith is based on zinc-oxide thin film semi- 
s conductor technology and has recently been developed for 
measuring VSC (see, Shimura M et al., J.  Periodontol. 
67:396-402 (1994)). New Cosmos Electric Co. (Osaka, 
Japan) manufactures this device. This device, however, is 
limited because it is susceptible to interference from organic 
i o  vapors unrelated to oral malodor (see, Yaegaki K, In 
Rosenberg, “Bad Breath: Research Perspectives,” Proceed- 
ings of the First International Workshop on Oral Malodor, 
Ramot Publishing, Tel Aviv University pp. 41-54 (1993)) 
87-108 (1995)). 
Another analysis for breath detection is a test based on the 
enzyme substrate benzoyl-DL-arginine-naphthylamine 
(BANA) (see, Loesche et al., J .  Clin. Microbiol 
28:1551-1559 (1991); and Loesche et al. J .  Periodontol., 
61:189-196 (1991)). This test is marketed under the brand 
20 name Peroscan and is available from Oral-B Laboratories 
(Redwood City, Calif.). Scrapings from the tongue, saliva, or 
plaque samples are deposited directly on a reagent card. 
Following substrate addition, a blue spot develops if anaer- 
obes are present. Studies have shown that BANAresults are 
25 not highly correlated with VSC measurements and that the 
test is often detecting other analytes (see, Kozlovsky et al., 
J .  Dent. Res., 73:1036-1042 (1994)). 
It has been estimated that at least 50% of the population 
suffers from chronic oral malodor (see, Bosy, J.  Can. Dent. 
30 Assoc. 63:196-201 (1997)). A significant fraction of the 
population is worried about bad breath, even though there is 
usually no underlying disease (see, Iwakura et al., J .  Dent. 
Res. 7:1568-1574 l(1994)). Food, of course, is another 
cause of oral malodors. However, there are many people 
35 who have an unwarranted phobia of bad breath. The size of 
the market for breath fresheners, chewing gums, and mouth 
rinses is an indicator of this propensity. 
In addition to mammalian breath measurements, respira- 
tory devices for anesthetic and respiratory gas mixtures must 
40 be monitored at very low concentrations of analytes. Medi- 
cal devices mix the anesthetic with breathing gas prior to 
delivery to the patient. In an anesthetic device, it is impera- 
tive that the concentration of the anesthetic, gas flow and 
amounts of the mixture and starting gases be known with 
45 certainty. In most instances, the anesthetic amounts are at 
very low concentration levels. 
One approach to increase sensitivity to certain analytes is 
to use selective filters or membranes. For instance, U.S. Pat. 
No. 5,841,021, which issued to De Castro et al., discloses an 
SO electrochemical gas sensor that has a catalytically active 
sensor electrode, a reference electrode and a permselective 
filter or membrane layer. The filter is made of a material that 
provides for molecular specificity of certain gases, such as 
carbon monoxide. The membrane allows the sensors to be 
ss selective to the chemical analyte of interest. The filter only 
allows the analytes of interest to contact the sensor. By 
removing interfering substances through filtration, the sen- 
sor becomes more selective and thus sensitive to the analyte 
of interest. 
In addition, U.S. Pat. No. 5,057,436, which issued to Ball, 
discloses a method and apparatus for detection of toxic 
gases, such as ammonia, using a metal oxide semiconductor 
and an electrochemical sensor. Disposed between the two 
sensors is an absorber having an absorbent that reacts with 
In view of the foregoing, what is needed in the art is a 
vapor concentrator for an array of sensors, especially for an 
is 
60 
65 ammonia. 
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electronic nose sensor array. In addition, methods are needed 
to detect odors and diagnose medical conditions. The present 
invention fulfills these and other needs. 
SUMMARY OF THE INVENTION 
In certain instances, it is desirable to measure trace 
amounts of analytes using sensor array technology. The 
present invention increases the sensitivity to such analytes 
by a large factor, and thus allows for the use of existing 
sensor systems for applications where an increase in sensi- 
tivity renders them more effective. As such, in certain 
aspects, the present invention provides a device for detecting 
the presence of an analyte, the device comprising: a sample 
chamber having a fluid inlet port for the influx of the analyte; 
a fluid concentrator in flow communication with the sample 
chamber, wherein the fluid concentrator has an absorbent 
material capable of absorbing the analyte and capable of 
desorbing a concentrated analyte; and an array of sensors in 
fluid communication with the concentrated analyte. In cer- 
tain preferred embodiments, the device further includes a 
detector operatively associated with each sensor that pro- 
vides a response in the presence of the analyte. 
The absorbent material of the fluid concentrator can be, 
but is not limited to, a nanoporous material, a microporous 
material, a chemically reactive material, a nonporous mate- 
rial and combinations thereof In certain instances, the absor- 
bent material can concentrate the analyte by a factor that 
exceeds a factor of about lo5, and more preferably by a 
factor of about 10’ to about lo4. Using the device of the 
present invention, the analyte can be concentrated from an 
initial sample volume of about 10 liters and then desorbed 
into a concentrated volume of about 10 milliliters or less, 
before being presented to the sensor array. 
In another embodiment, removal of background water 
vapor is conducted in conjunction, such as concomitantly, 
with the concentration of the analyte. Once the analyte is 
concentrated, it can be desorbed using a variety of 
techniques, such as heating, purging, stripping, pressuring or 
a combination thereof. 
In yet another aspect, the present invention provides 
methods for detecting or diagnosing, for example, 
infections, lung cancer, oral infections and halitosis using a 
breath sample of a mammal Preferably, the mammal is a 
human being. In other embodiments, the present invention 
provides methods for other medical applications, such as 
those involving the detection of marker gas(es) in mamma- 
lian breath as well as odors from potentially infected areas 
of the skin. 
In still yet another aspect, the present invention provides 
methods and devices for the process control of anesthetic 
gases of clinical interest. Using the apparatus of the present 
invention, monitoring and quantitating anesthetics is readily 
accomplished. 
These and other embodiments and advantages will be 
readily apparent when read with the accompany drawings 
and the detailed description of the invention which follows. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a cross-sectional view of a breath collector and 
FIG. 2 is a cross-sectional view of a breath collector and 
FIG. 3 is a head space analyzer of the present invention. 
FIG. 4 is a block diagram of a vaporizing system of the 
concentrator of the present invention. 
concentrator of the present invention. 
present invention. 
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FIG. 5 illustrates various response patterns obtained using 
the devices of the present invention. Panel A illustrates the 
responses of 32 sensors to anerobius (Bacl), gingivalis 
(Bac2) and a control; Panel B illustrates responses of 32 
sensors to anerobius (Bacl), gingivalis (Bac2) and a control 
(Expanded y-axis). 
FIG. 6 illustrates the results of principle component 
analysis on a data set of Ps anerobius (Bacl) and P gingivalis 
bacteria (Bac2) plus the control (the medium in which the 
bacteria were grown). 
FIG. 7 illustrates the response of sensors in the presence 
of 3 percent halothane. 
FIG. 8 illustrates the results of the response of sensor 
array in the presence of halothane. 
DETAILED DESCRIPTION OF THE 
INVENTION AND PREFERRED 
EMBODIMENTS 
I. The Device 
In one aspect, the present invention allows existing sensor 
systems to be more effective and efficient by providing 
enhancements in the detection sensitivity to trace analytes. 
As such, in one embodiment, the present invention provides 
a device for detecting the presence of an analyte in a fluid, 
comprising: 
a) a sample chamber having a fluid inlet port for the influx 
of the analyte; 
b) a fluid concentrator in flow communication with the 
sample chamber, the fluid concentrator having an 
absorbent material capable of absorbing the analyte and 
capable of desorbing a concentrated analyte; and 
c) an array of sensors in fluid communication with the 
concentrated analyte. 
In preferred embodiments, the device further comprising 
a detector operatively associated with each sensor that 
provides a response in the presence of an analyte. In certain 
embodiments, the sample chamber is designed for the col- 
lection of mammalian breath. Under certain conditions, 
mammalian breath contains marker gases indicative of cer- 
tain infections, disorders and medical conditions and the 
devices of the present invention can be used to detect such 
marker gases. In certain aspects, the sample chamber is a 
breath collector and concentrator (BCC) and is fabricated to 
collect the breath of a mammal. Preferably, the mammal is 
a human being, although the BCC can be fabricated to 
collect the breath of other mammals such as cows, sheep, 
horses, dogs, cats, hogs, etc. The BCC is convenient to use 
and in certain instances is a portable handheld device with 
a suitable handle portion for convenient use. 
With reference to FIG. 1, in certain embodiments, the 
sample chamber is a cylindrical reservoir having an inlet 
port (10) for the influx of gas, such as breath, and an outlet 
port (19) for the exhaust of breath. The BCC has a first end 
and a second end. The cylindrical container (12) extends 
between the first end and the second end, and the cylindrical 
container has an open interior chamber (13). 
The first end of the body is open for access to the interior 
chamber and functions as a breath inlet port and is vented by 
a breath exhaust. The breath inlet port optionally contains a 
disposable adapter for multiple use. A concentrator portal 
(14) opens into the interior chamber and is in flow commu- 
nication with the fluid concentrator. The fluid concentrator 
(15) comprises an absorbent material capable of absorbing 
the analyte and capable of desorbing a concentrated analyte. 
In certain embodiments, valves control the breath flow so the 
sample of breath within the chamber can be directed to the 
US 6,841,391 B2 
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fluid concentrator. The fluid concentrator optionally contains 
a second exhaust or exit port. 
A valve (16) is mounted anterior to the outlet port with 
sufficient force to maintain the vent closed except when the 
mammal is exhaling into the chamber. Optionally, the fluid 
concentrator is jacketed (17) with a heater for the purpose of 
desorbing a concentrated analyte. As illustrated in FIG. 1, 
the BCC has a sensor array portal (18) that opens into the 
interior chamber and is in fluid communication with the 
desorbed concentrated analyte and the sensor array (11). In 
ing includes a robotic armature system. In general, these 
systems include automated workstations like the automated 
apparatus developed by Takeda Chemical Industries, LTD. 
(Osaka, Japan) and many robotic systems utilizing robotic 
s arms (Zymate 11, Zymark Corporation, Hopkinton, Mass.; 
Orca, Hewlett-Packard, Palo Alto, Calif.), which mimic the 
manual operations performed by a technician. The nature 
and implementation of modifications to these devices (if 
any) so that they can operate will be apparent to persons 
i o  skilled in the relevant art. 
certain embodiments, the sensor array is disposed down- In operation, a volume of the gas to be sampled, such as 
stream of the inlet port and the concentrator portal. In other human breath, is introduced into a sample chamber where it 
embodiments, the sensor array is disposed between the inlet is transported by means of convention into the vicinity of the 
port and the concentrator portal (not shown). In certain sorbent material. Suitable transporting means include, but 
embodiments, the BCC has an adapter to provide breath is are not limited to, a fan, an air pump, or it can be means for 
from the nostril(s) to avoid cross-contamination from the heating the cylindrical container (12) to create a convective 
mouth. air flow between the inlet and the outlet. The sorbent 
In certain aspects, the BCC can be a desktop model. As material is chosen from known materials designed for the 
illustrated in FIG. 2, the first end (24) of the BCC (20) is purpose of sorbing gases, vapors, and the like. In certain 
open for access to the interior chamber (22) and functions as 20 embodiments, the sorbent material includes, but is not 
a breath inlet port and is vented by a breath exhaust (25). A limited to, a nanoporous material, a microporous material, a 
fluid concentrator (23) opens into the interior chamber (27) chemically reactive material, a nonporous material and 
and is in flow communication (28) with the breath exhaust combinations thereof Such absorbents include, for example, 
(25). In this embodiment, the breath is circulated through the activated carbon, silica gel, activated alumina, molecular 
chamber using a fan (21). The sensor array (26) is in flow zs sieve carbon, molecular sieve zeolites, silicalite, AlPO,, a 
communication with the desorbed analyte. polymer, a co-polymer, alumina and mixtures thereof In 
In various embodiments, the fluid concentrator can be certain embodiments, the absorbent has a pore size from 
disposed within the sample chamber or outside the sample about 1 nm to about 100 nm and, preferably, from about 1 
chamber. In addition, the sensor array can be disposed nm to about 50 nm. 
within the sample chamber or outside the sample chamber. 30 Suitable commercially available adsorbent materials are 
Moreover, the sensor array can be configured to be external disclosed in U.S. patent application Ser. No. 091271873, 
from the BCC and to extend into the mouth or nasal cavity. filed Mar. 18, 1999, and include, but are not limited to, 
The present invention embodies all such variations. Tenax TA, Tenax GR, Carbotrap, Carbopack B and C, 
Although the device of FIG. 1 is shown as a handheld Carbotrap C, Carboxen, Carbosieve SIII, Porapak, 
breath collector and concentrator, those of skill in the art will 3s Spherocarb, and combinations thereof Preferred adsorbent 
appreciate that in certain other embodiments, the device and combinations include, but are not limited to, Tenax GR and 
methods of the present invention can be adapted and con- Carbopack B; Carbopack B and Carbosieve SIII; and Car- 
figured to detect within or around various other areas of bopack C and Carbopack B and Carbosieve SI11 or Car- 
interest including, but not limited to, mucous membranes, boxen 1000. Those skilled in the art will know of other 
nose, nasal passages, eye, skin, ear, inner ear, mouth, tongue, 40 suitable absorbent materials. 
throat, colon, duodenum, body cavities, stomach, vagina and After sometime period that is chosen to be adequate for 
penis. Moreover, the device and methods of the present sorbing the desired analytes from the vapor phase onto the 
invention can be configured to detect all body fluids material, the circulation is stopped and then the material is 
including, but not limited to, urine, perspiration, tears, desorbed from the sorbent phase and released into the sensor 
blood, mucus, pus, salvia, feces, menstruation fluid, sperm, 4s chamber. The desorbing of the concentrated analyte for the 
eggs, spinal fluid and mammary gland discharge. sorbent can be by accomplished by thermal means, mechani- 
In another embodiment, the sample chamber is a head cal means or a combination thereof Desorption methods 
space analyzer (HSA) and can be fabricated from an inert include, but are not limited to, heating, purging, stripping, 
material, such as a molded fiberglass, or in certain embodi- pressuring or a combination thereof. 
ments can be fabricated from plastic and can be configured SO In certain embodiments, the sample concentrator is 
like a box. As illustrated in FIG. 3, the sample chamber (32) wrapped with a wire through which current can be applied 
optionally has a glass-viewing window and the box can to heat and thus, desorb the concentrated analyte. The 
contain pressure and temperature gauges (37) to allow analyte is thereafter transferred to the sensor array. 
pressure and temperature monitoring. Moreover, the sample The process of sorbing the material onto the sorbent phase 
chamber optionally contains valves for gas input and ss not only can be used to concentrate the material, but also can 
exhaust of the box. Optionally, the sample chamber com- be advantageously used to remove water vapor. The water 
prises a heater and a pressure control means for an internally vapor is preferably removed prior to concentrating the 
controlled atmosphere. analyte; however, in various embodiments, the vapor can be 
Similar to the BCC, the HSA has a first end (34) that is removed concomitantly or after the analyte is concentrated. 
open for access to the interior chamber (32) and functions as 60 In a preferred embodiment, the water vapor is removed prior 
an inlet port (30) and is vented by an exhaust (35). A fluid to presenting the desired analyte gas mixture to the sensor 
concentrator (33) is disposed outside the sample chamber array. Thus, in certain embodiments, the fluid concentrator 
and is in flow communication (36) with the exhaust (35). contains additional absorbent material to not only concen- 
The sensor array (39) is in flow communication with the trate the analyte, but to remove unwanted materials such gas 
desorbed analyte. 
Optionally, the HSA contains appropriate connections for In certain instances and depending on the absorbent used, 
high throughput screening (HTS). High throughput screen- the concentration factor can exceed a factor of lo5, and more 
65 contaminates and moisture. 
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preferably by a factor of about 10’ to about lo4. Thus, the sensing the presence of an analyte in a fluid with a chemical 
analyte gases can be concentrated from an initial sample sensor comprising first and second conductive leads electri- 
volume of about 10 liters and then desorbed into a volume cally coupled to and separated by a chemically sensitive 
of about 10 milliliters or less when they are presented to the Sensor as described above by measuring a first response 
sensor array. s between the conductive leads when the sensor is contacted 
The array of Sensors is present in fluid communication with a first fluid comprising an analyte at a first concentra- 
with the concentrated analyte. Various sensors suitable for tion and a second different response when the is 
detection of analytes include, but are not limited to: surface contacted with a second fluid comprising the analyte at a 
acoustic wave sensors; quartz sensors; second different concentration, As discussed above, suitable 
conductive composites; chemiresitors; metal oxide gas i o  responses include, but are not limited to, resistance, sensors, such as tin oxide gas sensors; organic gas sensors; 
devices; infrared sensors; temperature sensors, humidity 
metal FETstructures; metal oxide sensors, such as a Tuguchi for the 
gas sensors; phthalocyanine sensors; e~ectrochemica~ cells; 15 detection, identification, and classification of trace gas 
conducting polymer sensors; catalytic gas sensors; organic components, and are extremely useful in a variety of 
semiconducting gas sensors; solid electrolyte gas sensors; applications, including medical applications. In certain 
piezoelectric quartz crystal sensors; dye-impregnated poly- aspects, the methods and devices of the present invention are 
mer films on fiber optic detectors; polymer-coated micro- useful and very effective for the detection and diagnosis of 
mirrors; electrochemical gas detectors; chemically sensitive 20 diseases. In general, certain volatile marker gas (es) char- 
field-effect transistors; carbon black-polymer composite acterizes the detection or diagnosis of a disease state or 
chemiresistors; micro-electro-mechanical system devices; medical condition. The methods and apparatus of the present 
and micro-opto-electro-mechanical system devices and invention can advantageously by used to detect volatile 
Langmuir-Blodgett film sensors. marker gases and compounds indicative of medical 
In a preferred embodiment, the sensors used in the present zs conditions, disease processes, infections, illness and well- 
invention are disclosed in U.S. Pat. No. 5,571,401, which is being. Using these marker gases and compounds, clinicians 
incorporated herein by reference. Briefly, the sensors can use the diagnostic instruments and methods of the 
described therein are conducting materials and nonconduct- present invention to make diagnoses and formulate appro- 
ing materials arranged in a matrix of conducting and non- priate treatments. The methods as described can optionally 
conducting regions. The nonconductive material can be a 30 be performed using a fluid concentrator as described herein. 
nonconducting polymer such as polystyrene. The conductive A. Oral Infections 
material can be a conducting polymer, carbon black, an In certain aspects, the present invention is extremely 
inorganic conductor and the like. The sensor arrays comprise useful for the detection of infections, such as oral infections 
at least two sensors, typically about 32 sensors, and in and dental cares. For example, bacteria cause two wide- 
certain instances 1000 or more sensors up to about lo6 35 spread dental problems-halitosis and periodontal disease- 
sensors. In a preferred embodiment, at least two sensors are and, as disclosed herein, the methods and apparatus of the 
compositionally different. The array of sensors can be present invention can detect the off-gases produced by such 
formed on an integrated circuit using semiconductor tech- bacteria. 
nology methods, an example of which is disclosed in PCT 1. Halitosis 
Patent Publication No. WO99108105, entitled “Techniques 40 Halitosis is caused by the breakdown of proteins by 
and Systems for Analyte Detection,” published Feb. 19, microbes on the back of the tongue. The tongue coating is 
1999, and incorporate herein by reference. Another preferred comprised of epithelial cells from the oral mucosa, leuko- 
sensor system is disclosed in PCT Patent Publication No. cytes from periodontal pockets, and microorganisms. While 
WO99127357, published Jun. 6, 1999. the mouth is resident to over 300 bacterial species (see, 
In certain embodiments, the temporal response of each 45 Loesche et al., In Rosenberg M., Editor, “Bad Breath: 
sensor (response as a function of time) is recorded and can Research Perspectives,” Proceedings of the First Znterna- 
be displayed. Various responses include, but are not limited tional Workshop on Oral Malodor, Ramot Publishing, Tel 
to, resistance, impedance, capacitance, inductance, Aviv University pp. 41-54 (1993)), the relative size of each 
magnetic, optical, etc. The temporal response of each sensor population is a function of many factors. Bad breath has 
can be normalized to a maximum percent increase and SO been associated with the expansion of anaerobic species 
percent decrease that produces a response pattern associated (see, Loesche et al., In Rosenberg Ed., “Bad Breath: 
with the exposure of the analyte. By iterative profiling of Research Perspectives,” Proceedings of the First Znterna- 
known analytes, a structure-function database correlating tional Workshop on Oral Malodor, Ramot Publishing, Tel 
analytes and response profiles is generated. Unknown ana- Aviv University pp. 41-54 (1993); de Boveri HE et al., J .  
lytes can then be characterized or identified using response ss Am. Dent. Assoc., 126:1384-1393 (1995)). The underlying 
pattern comparison and recognition algorithms. cause of the increase in anaerobes can be poor oral hygiene, 
Accordingly, analyte detection systems comprising sensor aging, deep crevices in the tongue, post-nasal drip, or 
arrays, a measuring device for detecting responses across numerous other conditions. 
each sensor, a computer, a display, a data structure of sensor The chemical markers of bad breath have been identified 
array response profiles, and a comparison algorithm(s) or 60 and include, but are not limited to, volatile sulfur com- 
comparison tables are provided. In another embodiment, the pounds (VSC) (see, Richter et al.,Arch. Oral Biol., 9:47-53. 
electrical measuring device or detector is an integrated (1964); Tonzetich, Arch. Oral Biol., 16:587-597 (1971); 
circuit comprising neural network-based hardware and a Tonzetich, J .  Periodontol. 48: 13-20 (1977); Tonztich J, J .  
digital-analog converter (DAC) multiplexed to each sensor, Znt. Dent. J .  28:309-319 (1978); and Tonzetich, Arch. Oral 
or a plurality of DACs, each connected to different sensor(s). 65 Biol., 16:587-597 (1971)). 
In certain embodiments, a method for using the sensors As such, the present invention provides a method for the 
for detecting the presence of an analyte in a fluid involves detection of halitosis, the method comprising: contacting an 
metal oxide field effect transistor (MOSFET); piezoelectric impedance, capacitance, inductance, magnetic, Optical, etc. 11. Medical Applications 
sensors, sintered metal oxide sensors; Pd-gate MOSFET; The methods and apparatus Of the present invention are 
and can be 
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array of sensors with mammalian breath suspected of con- 
taining a marker gas indicative of halitosis; and detecting the 
marker gas to determine the presence of halitosis. In pre- 
ferred embodiments, the marker gases being detected by the 
sensors are volatile sulfur compounds. 
2. Periodontal Disease 
A far more serious consequence of oral infections is 
periodontal disease. Gingivitis is the inflammation of the 
gums and periodontitis is when the gum infection damages 
the bone and supporting tissues. These conditions are the 
result of the expansion of certain species of bacteria. If a 
piece of food is trapped between the teeth, the bacterial types 
that can utilize the various nutrients present will multiply. In 
addition, some of their metabolic products can give rise to 
a second array of organisms. And finally, if the population 
explosion of bacteria is sufficient to elicit an inflammatory 
response, a third wave of bacteria can arise that prefers the 
gingival crevicular fluid (see, Loesche W J et al., In 
Rosenberg, Bad Breath Research Perspectives, Ramot 
Publishing, Tel Aviv, pp. 41-54 (1993)). 
VSC are also an indicator of periodontal disease (see, 
Loesche et al., In Rosenberg, Bad Breath: Research 
Perspectives, Ramat Publishing, Tel Aviv, (1995); Yaegaki et 
al.,J. Periodontia. Res. 27:233-238 (1992); Tonzetich et al., 
J .  Dent. Res 58:175 (1979); Frostell et al., Dent. J .  
20:436-450 (1970); Sat0 et al., Bull. Tokyo Dent. Coll., 
21:171-178(1980); Kostelc et al., J .  Periodontal Res. 
15:185-192(1980)). In addition, a number of other com- 
pounds can be indicative of various bacterial populations 
(see, Bosy et al., J.  Periodontal. 65:37-46 (1994); McCul- 
loch et al., In Rosenberg, Bad Breath Research Perspectives, 
Ramat Publishing, Tel Aviv, pp. 109-117 (1995)). 
Asignificant development in recent years has been the use 
of anti-microbials to treat periodontitis instead of surgery. It 
has been shown that 80% of patients scheduled for surgery 
or extractions could be successfully treated with a course of 
metronidazole, doxycycline, or chlorhecidine. Overall, only 
about 10% of the teeth required the conventional surgery or 
extraction. Surprisingly, by using the apparatus of the 
present invention, it is possible to make a quick diagnosis, 
thereby alleviating unnecessary surgery. 
As such, the methods and apparatus of the present inven- 
tion can be used for the detection of periodontal disease. 
Thus, the present invention provides a method for the 
detection of periodontal disease, the method comprising: 
contacting an array of sensors with mammalian breath 
suspected of containing a marker gas indicative of periodon- 
tal disease; and detecting the marker gas to determine the 
presence of periodontal disease. As explained above, and 
detailed hereinbelow, numerous marker gases can be used to 
detect and evaluate the severity of periodontal disease 
B. Pneumonia Detection 
In certain instances, it currently takes two to three days to 
culture the bacteria and determine whether the species that 
cause pneumonia are present. Often, rather than waiting for 
this determination, medical personnel prescribe broad- 
spectrum antibiotics. Unfortunately, this prophylactic pro- 
cedure can promote the emergence of antibiotic-resistant 
strains . 
The methods and devices of the present invention can 
alleviate the unnecessary prescribing of antibiotic(s) by 
providing rapid accurate detection and diagnosis of bacteria 
attributable to pneumonia. Thus, the present invention pro- 
vides a method for the detection of pneumonia, the method 
comprising: contacting an array of sensors with mammalian 
breath suspected of containing a marker gases indicative of 
pneumonia; and detecting the marker gas to determine the 
presence of pneumonia. 
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C. Wound Healing 
One of the major reasons for slow healing wounds can be 
a high level of bacteria. Frequently, wound healing is largely 
undetected due to lack of tests for detecting microorganisms. 
Slow wound healing is a problem that effects more than a 
million people each year and costs billions of dollars to treat. 
Unfortunately, one of the standard techniques of wound 
assessment is to smell the exudate on the dressing. Nurses 
are advised to be aware of a “repulsive” odor that may be 
associated with necrotic tissue and “acrid or putrid” smells 
that are associated with anaerobic bacteria. 
However, these methods suffer from lack of specificity. 
While the absence of odor is indicative of a clean wound, the 
presence of odor does not necessarily signal an infection The 
switch in recent years to moisture-retaining “wet dressings” 
has further complicated the problem of wound assessment. 
Most dressings have strong odors, but often times the odor 
is due entirely to the materials in the dressings. 
While there is a quantitative culture methodology that can 
be employed to eliminate human errors, it is very expensive 
and time consumingh such, it is only used routinely in burn 
centers where patients are in much more serious conditions. 
Advantageously, the present invention provides a method 
for diagnosing wound healing comprising: contacting the 
vapors associated with the wound with an array of sensors, 
thereby assessing the wound healing process. 
D. Vaginitis 
The vaginal discharge of women with bacterial vaginitis 
often has a prominent fishy odor. The presence of 
methylamine, isobutylamine, putrescine, cadaverine, 
histamine, tyramine, and phenethylamine are marker gases 
of vaginitis (see, Brand et al., Obstetrics and Gynecology, 
68,682-685 (1985)). Thus, the present invention provides a 
method for the detection of vaginitis, the method compris- 
ing: contacting an array of sensors with vaginal vapors or 
discharge suspected of containing a marker gas indicative of 
vaginitis; and detecting the marker gas to determine the 
presence of vaginitis. 
E. Fertility 
In yet another aspect, the present invention provides 
methods and apparatus for the detection of ovulation. The 
fertile period of a female mammal, such as a human being, 
can be detected by measuring axillary secretions. The mark- 
ers are androstenol and/or dehydroepiandrosterone sulfate. 
Thus, the present invention provides a method for detecting 
ovulation, the method comprising: contacting an array of 
sensors with vaginal vapor for the presence of a marker gas 
indicative of ovulation; and detecting the marker gas to 
determine ovulation. 
F. Other Applications 
In addition to the foregoing applications, other applica- 
tions for the methods and devices of the present invention 
include, but are not limited to, environmental toxicology, 
remediation, biomedicine, material quality control, food 
monitoring, agricultural monitoring, heavy industrial 
manufacturing, ambient air monitoring, worker protection, 
emissions control, product quality testing, oiligas petro- 
chemical applications, combustible gas detection, H,S 
monitoring, hazardous leak detection, emergency response 
and law enforcement applications, explosives detection, 
utility and power applications, foodlbeverageiagriculture 
applications, freshness detection, fruit ripening control, fer- 
mentation process monitoring and control, flavor composi- 
tion and identification, product quality and identification, 
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refrigerant and fumigant detection, cosmeticiperfume detection, infectious disease detection, breath analysis and 
applications, fragrance formulation, chemicaliplasticsi 
pharmaceut ica ls  applications,  fugit ive emission 
identification, solvent recovery effectiveness, hospital/ 
medical applications, anesthesia and sterilization gas gens are set forth in Table 1 
body fluids analysis. 
Various other medical conditions and associated patho- 
TABLE 1 
INFECTIONS AND PATHOGENS 
Infection Pathogen Area of Interest 
Acute sinusitis 
Pharyngitis 
Pneumonia 
Bronchitis 
American Thoracic 
Society (ATS) Class 111 ( 
Severe CAP 
ATS Class IV-ICU 
ZAP 
Cystitis in females; 
Pyelonephritis; Prostatitis or 
Epididymoorchitis 
Acute Meningitis 
Meningitis (post surgical); 
Brain abscess 
Biliary tract; Peritonitis or 
Diverticular abscess 
Cellulitis; Lymphangitis 
Cat bite, Dog bite, Decubitus 
ulcers, (uncomplicated) or 
Diabetic foot ulcer 
(uncomplicated); Toxic Shock 
EndometritisIEndomyometritis 
Pelvic Inflammatory Disease; 
Septic Thrombophlebitis 
(postpartum) 
Endocarditis (IE) 
Prosthetic valve 
Septic arthritis, Prosthetic 
joint, Osteomyelitis 
Strep. pneumoniae, H. flu, 
Moraxella catarrhalis, Group 
A strep., G(+) anaerobes, 
Staph. aureus 
Group A, C, G strep. 
Strep. pneumoniae, 
Mycoplasma, Chlamydia 
pneumoniae, H. flu 
Strep. pneumoniae, H. Flu, 
Moraxella 
Strep. pneumoniae, H. 
influenzae, Klebsiella, Staph. 
aureus, Legionella Sp., 
Pseudomonas aerug., 
other gram-negative bacteria; 
Strep. pneumoniae, Staph. 
aurew, Legionella Sp., 
Pseudomonas aerug., other 
gram negative bacteria 
Enterobacteriaceae; 
Enterobacteriaceae & 
Enterococcus sp. 
Hemophilus influenzae, 
Pneumococci, N. meningitidis 
Staphylococcus sp., gram- 
negative bacteria; 
Streptococcus sp., anaerobes, 
Staph. sp. 
Enterobacteriaceae, 
Enterococcus sp., anaerobes 
Streptococcus sp.; 
Staphylococcus sp.; Pasturella 
multicida, Staph & Strep., 
anaerobes; Gram negative 
bacteria; Gram-positive 
bacteria; Anaerobes 
Enterobacteriaceae, 
Chlamydia sp., Streptococcus 
sp. (group B Streptococcus), 
Neiserria gonorrhoeae 
Streptococci sp. 
Staphylococcus sp. 
Staphylococcus epi. 
Staphylococcus sp. & Strep. 
sp., Neisseria gonorrhoeae, 
Staphylococcus sp., 
Staphylococcus sp., Staph & 
Strep. sp., Enterobacteriaceae, 
anaerobes 
Sinus 
Pharynx 
Lungs 
Lungs 
Lung 
Urinary Tract 
CNS 
Abdomen 
Skin 
Pelvis 
Heart 
Bone & Joint 
G. Markers 
As explained above, volatile sulfur compounds (e.g., H,S, 
C H , S H ,  CH,S-CH,) are the marker gases implicated 
in halitosis and periodontal diseases (see, Tonzetich, Arch. 
Oval Biol., 16:587-597 (1971); Rizzo, Periodontics, 
5:233-236 (1967)). Other analytes that have been shown to 
correlate with such clinical findings include, but are not 
limited to, volatile organic acids (VOA), indoleiskatole 
(indole), and diamines (see, Goldberg et al., J .  Dent. Res., 
73:1168-1172(1994); Goldberg et al., In Rosesberg M Bad 
Breath Research Perspectives, Ramat Publishing, Tel Aviv, 
pp. 71-85 (1995)). 
In addition, several other analytes have been reported to 
picolines (see, Kostelc et al., J .  Peviodont. Res., 15:185-192 
ss (1981); Kostelc et al., Clin. Chem., 27342-845 (1981)). 
Overall, more than 80 volatile compounds have been shown 
to be associated with saliva or tongue scrapings (see, Claus 
et al., J.  High Resol Chvomatogr, 20:94-98 (1997)) and the 
methods and apparatus of the present invention can be used 
60 to advantageously detect such marker compounds and gases. 
Using the methods and apparatus of the present invention 
it is also possible to detect the off-gasses associated with 
bacteria associated with oral maladies including, but not 
limited to, Pvevotella intevmedia; Fusobacterium nuclea- 
65 tum; Povphyvomonas gingivalis; Povphyvomonas endodon- 
talis; Pvevotella loescheii; Hemophilus pavainfuenzae; Sto- 
be associated with oral infections including pyridines/ matococcus muci; Treponema denticola; Veillonella species, 
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Peptostveptococcus anaevobius; Micros pvevotii; Eubacte- 
rium limosum; Centipeda peviodontii; Selemonad avemidis; 
Eubacterium species; Bacteriodes species; Fusobacterium 
peviodonticum; Pvevotella melaninogenica; Klebsiella 
pneumoniae; Entevobactev cloacae; Citrobacter species and 
Stomatococcus mucilaginus. 
Moreover, a wide variety of analytes and fluids can be 
detected and analyzed using the disclosed sensors arrays and 
electronic noses so long as the subject analyte(s) and fluids 
are capable of generating a differential response across a 
plurality of sensors of the array. Analyte applications include 
broad ranges of chemical classes including, but not limited 
to, organics such as alkanes, alkenes, alkynes, dienes, ali- 
cyclic hydrocarbons, arenes, alcohols, ethers, ketones, 
aldehydes, carbonyls, carbanions, polynuclear aromatics 
and derivatives of such organics, e.g., halide derivatives, 
etc.; biomolecules such as sugars, isoprenes and isoprenoids; 
VOC; VOA; indoles; skatoles; diamines; pyridines; 
picolines; fatty acids; and derivatives of the forgoing, etc. 
In addition to breath, the sensor arrays of the present 
invention can be used to identify various analytes in other 
biological fluids. These fluids include, but are not limited to, 
urine, perspiration, tears, blood, mucus, pus, salvia, feces, 
menstruation fluid, sperm, eggs, spinal fluid and mammary 
gland discharge. 
In general, most conditions and diseases listed herein 
have microorganisms associated with them. The presence of 
marker gases and compounds associated with the microor- 
ganism is in turn, indicative of the presence of the disease or 
condition. In a preferred embodiment, the off-gas of the 
microorganism is the marker that is detected by methods and 
devices of the present invention. 
111. Anesthetics 
In certain anesthetic vaporizers, a carrier gas, such as air, 
oxygen or nitrous oxide, is divided between a first stream 
directed to a chamber, wherein an anesthetic liquid is 
resident and a second stream or bypass stream. The first and 
second streams are recombined before delivery to the 
patient. Another version of an anesthetic vaporizer is 
embodied in a device wherein the anesthetic agent is 
injected directly into the carrier gas stream. 
In either instance, it is imperative that the concentration of 
volatile as anesthetic liquid be known. The present invention 
provides methods and an apparatus for the process control of 
anesthetic gases. Using the methods and apparatus of the 
present invention, a fluid concentrator is optionally used 
when monitoring and quantitating anesthetic concentration. 
By using the apparatus and sensors described herein, it is 
possible to detect and quantitate the concentration of volatile 
anesthetics including, but not limited to, halothane, 
isoflurane, servoflurane, desflurane and enflurane. As such, 
the present invention provides an anesthetic vaporizing 
system for quantitating the concentration of the anesthetic, 
comprising: a carrier gas source for delivering a carrier gas 
stream to a bypass valve, wherein the bypass valve splits the 
carrier gas stream into a first carrier gas stream for delivery 
to an inlet port and a second carrier gas stream for delivery 
to a joining valve; 
a vaporizing chamber for an anesthetic agent, comprising 
the inlet port, an outlet port, a vaporizing means and a 
conduit for delivery of vaporized anesthetic from the 
outlet port to the joining valve; and 
an array of sensors in flow communication with the 
joining valve to quantitate the anesthetic. In preferred 
embodiments, the system further comprising a detector 
operatively associated with each sensor that provides a 
response in the presence of an anesthetic vapor. 
14 
With reference to FIG. 4, the carrier gas source (41) 
delivers the carrier gas to a bypass valve (44), wherein the 
carrier gas is split between a first carrier gas stream for 
delivery to the inlet port (45) of the anesthetic vaporizer (40) 
5 and a second carrier gas stream which connects to a joining 
valve (46). The anesthetic vaporizer contains a vaporizing 
means, such as a heater, pressure souce or aspirator (48). The 
vaporizer includes an outlet port (42) for delivery of the 
vaporized anesthetic through a conduit (43) to the joining 
valve. The sensor array (49) is in flow communication with 
the joining valve. 
The present invention also provides a method of quanti- 
tating an anesthetic vapor, comprising: containing the anes- 
thetic vapor with a sensor array to produce a response; 
detecting the response with a detector, thereby quantitating 
the anesthetic vapor. 
The following examples are meant to illustrate and not 
limit the present invention. 
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IV. EXAMPLES 
20 Example 1 
In this Example, the detection and identification of bac- 
teria was conducted by measuring the metabolic products 
produced from plate bacteria cultures carried out using an 
electronic nose (a 32-sensor array) and a Fisher Linear 
As shown herein, the data was also examined using 
principal component analysis (PCA) and statistical isolinear 
multicategory analysis (SIMCA). The results carried out on 
two very distinct bacteria, i.e., peptostveptococcus anevobius 
30 and povphyvomonas gingivalis, show that the two bacteria 
were clearly discriminated by the sensors as shown by PCA. 
The metabolites of additional an 11 bacteria and one fungus 
plus controls were tested and the data was examined using 
PCA, SIMCA and FLD and discrimination among the bac- 
The objective of these experiments was to evaluate the 
discriminating capability of a thirty-two sensor array com- 
posed of mixtures of polymers and carbon black for metabo- 
lites produced by a variety of bacteria. Fourteen fresh 
cultures were tested for the 20 most commonly suspected 
40 malodor producing, oral and pharyngeal anaerobic and fac- 
ultative bacteria including a fungus using a 32-sensor array. 
The experiment was done in two phases. The first phase 
consisted of testing two very distinct bacteria, peptostvep- 
tococcus anevobius and povphyvomonas gingivalis, plus a 
45 control (the media in which the bacteria were independently 
grown). Four sample tubes of each bacterium and the control 
were tested to investigate reproducibility. The results from 
the first test indicated that gingivalis and anerobius could be 
discriminated from each other and the control using a sensor 
Ten samples of eleven bacteria, a fungus and ten controls 
were tested with the same sensor array used described 
above. Table 3 lists the bacteria plus the main metabolite 
known to be produced by these bacteria. Various statistical 
ss and mathematical techniques were used to analyze the data 
obtained with chemiresistors on these microorganisms. One 
of the methods used to classify the metabolites produced 
from the various bacteria was principal component analysis, 
an unsupervised pattern recognition technique. PCA trans- 
60 forms multidimensional data sets into a lower dimensional 
graphical representation, which describes a majority of the 
variation in a data set. PCAdefines a new set of axes to plot 
the samples, they are constructed so that a maximum amount 
of variation is described with a minimum number of axes, 
65 and the data is hence readily visualized in this transformed 
data space (see, K. R. Beebe, R. J. Pell, M. B. Seasholtz, 
Chemometvics: A Practical Guide, Wiley, New York, 1998.) 
2s Discrimination (FLD) algorithm. 
35 teria was demonstrated. 
50 array discussed herein. 
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Another algorithm used to analyze the data set was Fisher 
Linear Discrimination (FLD). FLD seeks a linear combina- 
tion of the variables, which maximizes the ratio of its 
between-group variance to its within-group variance (see, B. 
D. Ripley, Pattern Recognition and Neural Networks, Uni- 
versity Press, Cambridge, 1996, Chapter 3, p 93.). 
Other algorithms used to analyze the data were K-nearest 
neighbor (KNN) and statistical isolinear multicategory 
analysis, SIMCA. Both of these algorithms are supervised 
pattern recognition methods used for predicting the class of 
unknown samples given a training set of samples with 
known class membership. With KNN, a classification is 
always made, whether or not the unknown is a member of 
the class in the training set. KNN is a much simpler 
algorithm than SIMCA because unlike SIMCA it makes no 
assumptions about the size or shape of the class. SIMCAcan 
detect if an unknown sample is not a member of any class 
in the training set. SIMCAuses the shape and position of the 
object formed by the samples in a class for class definition 
(see, K. R. Beebe, R. J. Pell, M. B. Seasholtz, Chemomet- 
rics:A Practical Guide, Wiley, New York, 1998). The results 
obtained using all the described algorithms are set forth 
below. 
A. Experimental 
1. Testing Protocol 
Thirty polymers were chosen based both on structural 
differences and on solubility to generate a thirty two sensor 
array. The testing protocol used for all the bacteria was the 
same and is described below. Anerobius and gingivalis were 
tested in one day, whereas the rest of the bacteria were tested 
over several days. 
Testing instrument: A Keithley electrometer and scanner 
were used to scan the resistances of 32 sensors during the 
experiment. 
Sampling: the headspace above the bacteria was sampled 
using nitrogen gas as the carrier. The flow rate used was 100 
mL/minute. No dilution with air was done. The flow rate of 
the background air used to purge the sensors was 10 
L/minute. No preconcentration was preformed. 
Temperature: The temperature of the substrates was not 
controlled and the measurements were done at room tem- 
perature for the first phase study. The temperature of the 
substrates was maintained at 28+0.1" C. for the second 
phase study. 
Purge and Exposure times: For each sample test, there 
were 60 seconds of background recording (purged with air), 
120 seconds of exposure time, 120 seconds of recovery time 
(purged with air with RH level of about 3%), 180 seconds of 
recovery without recording the data (purged with air), and 
30 seconds of final recording time (purged with air). 
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B. Results and Discussion 
1. Sensor Array Response 
The response pattern of the 32-sensor array described 
above to anerobius, gingivalis, and the control is shown in 
FIG. 5 .  Note that the reproducibility of the sensor array was 
very good. The response (the normalized resistance change, 
(R,ux-R,)/R,), where R, and R, are the maximum and 
base (initial) resistance, respectively) of the sensor array to 
each sample tested is employed to form a covariance matrix, 
which is used to do principal component analysis. PCA of 
the two bacteria plus control (data not shown) were clearly 
discriminated by the sensor array. SIMCA was also used to 
evaluate the data. The model was built with all the data as 
the training set and the data from the first test was used as 
the unknown. A classification rate of 100% was obtained 
using the SIMCA algorithm. KNN was also used to examine 
the data set. A model was built using the data from three 
sample tubes of each bacteria plus the control. One of the 
samples was used as the unknown. Using 3 or 5 nearest 
neighbors in the KNN algorithm gave a classification rate of 
66%. The FLD algorithm was not used on this data set. 
In the second phase study, ten samples of 11 bacteria and 
one fungus were tested. The temperature of the substrates 
was controlled at 28+0.1" C. for all tests. The sample tubes 
were not temperatures controlled. As described in the experi- 
mental section, each bacterium was tested 19 times among 
9 test tubes. Thirty-two sensors responded to 11 bacteria and 
one fungus, 19 times for each. A covariance matrix that 
contained 32 columns (one column for each sensor 
response) and 12x19 rows (bacteria tested at different times) 
was formed. This matrix was used to do principal compo- 
nent analysis. 
A different algorithm, Fisher Linear Discrimination, was 
introduced to process the data set. To construct a model 
using the FLD method, it is required that the data take the 
form of a square matrix. The columns and rows in the matrix 
correspond to the number of sensors and the number of test 
samples, respectively. Hence, to use FLD, the number of 
sensors needs to be equal to the number of sample tests. 
Each of the 11 bacteria and one fungus were tested 19 times 
thus, only 19 sensors could be used to construct the FLD 
model. Hence, a square matrix was formed using each of the 
bacteria tested 19 times and choosing 19 sensors out of the 
32. The very first test (tube 1) and the last test (tube 5) of 
each bacterium were used as unknowns. The first 19 sensors 
out of the 32-sensor array were found to give the highest 
prediction rate out of other sensor combinations. Twenty- 
four unknowns were predicted from the FLD model. The 
results provided a classification rate of 91.7% (see, Gibson, 
T. D., Prosser, O., Hulbert, J. N., Marshall, R. W., Corcoran, 
P., Lowery, P., Ruck-Keene, E. A,, Heron, S., Sensors and 
Actuators (B) 44, 413422,  1997). 
As a comparison, a SIMCAmodel was built with the same 
training set used for the FLD analysis. The same 24 
unknowns was used for SIMCA prediction. The results 
provided a classification rate of 75%. The KKN algorithm 
was also used and the classification rate was 66%. 
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TABLE 2 
18 
SENSOR COMPOSITION AND DEPOSITION CONDITIONS 
Sensor 
P’er # Po 1 y m e r # Solvent Ratio 
19 
22 
34 
3s 
36 
5s 
73 
74 
3 
10 
12 
39 
42 
41 
48 
so 
54 
59 
63 
68 
80 
87 
9s 
79 
63 
79 
86 
82 
90 
104 
10s 
102 
CHIP EM-1-070798 
Hydroxypropyl cellulose 
Methyl vinyl ether-co-maleic acid, 50150 
Polyacrylamide 
Polyacrylamide, carboxyl modified (LC) 
Polyacrylamide, carboxyl modified (HC) 
Poly(ethy1ene oxide) 
Poly(viny1 alcohol), 100% hydrolyzed 
Poly(viny1 alcohol), 98% hydrolyzed 
CHIP EM-2-070798 
Alginic acid, sodium salt 
Ethylene-co-ethyl acrylate, 82/18 
Ethylene-co-vinyl acetate, 86/14 
1,2-Pol ybutadiene 
Polycaprolactone 
Poly(n-butyl methacrylate) 
Poly(n-ethyl methacrylate) 
Polyethylene, chlorinated (42& Cl) 
CHIP EM-3-070798 
Sr 1 
Sr 2 
Sr 3 
Sr 4 
Sr 5 
Sr 6 
Sr 7 
Sr 8 
Sr 9 
Sr 10 
Sr 11 
Sr 12 
Sr 13 
Sr 14 
Sr 15 
Sr 16 
Polyethylene, chlorosulfonate 
Poly(isobuty1 methacrylate) 
Poly(a-methyl styrene) 
Polystyrene 
Poly(viny1 stearate) 
Styrenelethylenebutylene, ABA block 
Vinyl chloridelvinyl acetatelhydroxypropyl 
Poly(viny1 pyrrolidone) 
CHIP EM-4-070798 
Poly(a-methyl styrene) 
Poly(viny1 pyrrolidone) 
Styrene-co-butyl methacrylate 
Styrene-co-acrylonitryle, 75/25 
Vinyl alcohol-co-vinyl butyral; 20180 
Poly (4-methoxy styrene) 
Poly methyl hydrosiloxane 
Poly diphenoxyphosphazene 
Sr 17 
Sr 18 
Sr 19 
Sr 20 
Sr 21 
Sr 22 
Sr 23 
Sr 24 
Sr 25 
Sr 26 
Sr 27 
Sr 28 
Sr 29 
Sr 30 
Sr 31 
Sr 32 
water 
water 
water 
water 
water 
water 
water 
water 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
water 
toluene 
water 
toluene 
THF 
THF 
THF 
THF 
THF 
150 to 1 
151 to 1 
150 to 1 
150 to 1 
150 to 1 
150 to 1 
150 to 1 
150 to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
150 to 1 
2s to 1 
150 to 1 
2s to 1 
100 to 1 
100 to 1 
100 to 1 
100 to 1 
100 to 1 
carbon black was used in each sensor at a concentration between 20-25 wt % 
TABLE 3 
LIST OF BACTERIA AND THEIR METABOLIC PRODUCTS 
BACTERIA NOMENCLATURE METABOLIC PRODUCTS OR OFF-GASES 
Enterobacter cloacae 
Cit. Koseri 
Psuedomonas Aeruginosa 
Veilonella species 
Prevotella melaninogenica 
Escherichia coli 
Klebsiella Pneumoniae 
Streptococcus mutans 
*Candida albicans 
Prevotella intermedia 
Fusobacterium nucleatum 
Staph. aureus 
Peptostreptococcus anerobius 
Porphyromonas gingivalis 
Bac 1 
Bac 2 
Bac 3 
Bac 4 
Bac 5 
Bac 6 
Bac 7 
Bac 8 
Bac 9 
Bac 10 
Bac 11 
Bac 12 
Isobutyric and isovaleric acid 
NIA 
NIA 
Acetic and propionic acid and 
isoamyl alcohol 
Isovaleric acid 
Acetic and propionic acid 
Methyl ethyl ketone, methylbutanal, 
2-butanol, pentanone, dimethyl sulfide, 
isobutanol, isopentylacetate, 2-heptanone 
isopentanol, 2-nonanone, 2-undecanone 
Acetic acid, propionic acid 
NIA 
Isovaleric acid 
Acetic, propionic and butyric acid 
Acetic, 2-butanone, 2-butanol, pentanone, 
methyl butanol, toluene, 2-heptanone, 
isopentanol, 2-nonanone, 2-undecanone, 
acetone, 2-nondecagon 
Acetic, isobutyric, butyric, isovaleric and 
isocaproic acid 
Isovaleric acid 
*This is a fungus 
US 6,841,391 B2 
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Example 2 these arrays are suitable for process control over the con- 
centration of anesthetic gases at levels that are clinically of 
interest. 
This Example illustrates that the apparatus and methods 
comarising the sensor arravs of the aresent invention are 
suitable for process control of anesthetic gases. As disclosed 
herein, a method for monitoring anesthetic gases in order to 
establish reliable monitoring of a patient,s condition while 
under anesthetics is possible. Conducting-polymer compos- 
ite sensors change resistance when exposed to an analyte in 
the vapor phase, and the pattern of such resistance changes 
across an array allows identification of a concentration of an 
analyte. The pattern height allows identification of the 
concentration of an analyte. The experiments show that 
Using a 18-sensor array a suitable concentration of hal- 
othane was delivered. The flow rate of the carbon dioxide 
carrier gas was 10 mL/min. The anesthetic gas flow rate was 
0.2 mL/min, thus the ratio of carrier gas flow Over the 
sm~mation ofthe carrier gas flow and the anesthetic gas flow 
was 2%. FIG. 7 illustrates the response of 2% halothane on 
the sensor array. FIG. 8 illustrates the linear response for 
sensor 10 with halothane concentration. 
TABLE 4 
18 SENSOR ARRAYS 
Sensor Polvmer and carbon black Carbon black 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
Poly(4-vinyl phenol) [24979-70-21 
MW 1500-7000 Polysciences Cat #06527 
0.160 g in 20 ml THF 
Pol y(Styrene-co-alkyllalcohol) 
Polysciences Cat N3773 
5.7% hydroxyl, MW 1500 
0.156 g in 20 ml THF 
Poly (a-methylstyrene) [25014-31-71 
Aldrich 
0.164 g in 20 ml THF 
Poly(viny1 chloride - vinylacetate) [9003-22-91 
10% vinyl acetate 
Polysciences Cat N7058 
0.164 g in 20 ml THF 
Poly(viny1 pyrrolidone) [9003-39-81 
Aldrich 
Average Mw 10,000 
(both in TFSH @ 6 mgiml) 
0.160 g in 20 ml THF 
Poly(viny1 acetate) [9003-20-71 
Pol ysciences 
M W  500,000 
0.163 g in 20 ml 
Poly(methy1 vinyl ether - maleic 
anhydride) [9011-16-91 
Polysciences Cat N 3 0 3  
0.162 g in THF 
Poly(bispheno1 A carbonate) [24936-68-31 
MW 32,000-36,000 
Polysciences Cat NO962 
0.169 g in 20 ml THF 
Poly(styrene) [9003-53-61 
MW 125,000-250,000 beads 
Polysciences Cat NO574 
0.160 g in THF 
Poly(styrene - maleic anhydride) [9011-13-61 
50% of each Mw 1600 
Polysciences Cat N 3 1 6  
0.160 g in 20 ml THF 
Poly(viny1 butyral) [63148-65-21 
Mw 100,000-150,000 
Polysciences Cat N 6 1 0 0  
0.160 g in 20 ml THF 
Poly(su1fone) [25135-51-31 
0.166 g in 20 ml THF 
Mw 30,000 
Polysciences Cat N 7 0 7 4  
Poly(methy1 methacrylate) [9101-14-71 
Aldrich 
Average Mw -120,000 
Contains 4 . 0 %  toulene 
0.162 g in 20 ml THF 
Poly(viny1idene chloride - acrylonetrile) [9010 
76-81 
0.161 g in THF 
Polysciences cat. N9747 
(8020)  
40 mg Carbon black 
(soluble in THF) 
.46 mg carbon black 
(soluble in THF) 
41 mg carbon black 
39 mg carbon black 
41 mg carbon black 
42 mg carbon black 
39 mg carbon black 
39 mg carbon black 
41 mg carbon black 
40 mg carbon black 
41 mg carbon black 
40 mg carbon black 
41 mg carbon black 
40 mg carbon black 
21 
TABLE 4-continued 
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18 SENSOR ARRAYS 
Sensor Polymer and carbon black Carbon black 
15. Poly(capro1actone) [24980-41-41 42 mg carbon black 
Polysciences cat. #07039 
Biodegradable polymer 
0.159 g in 20 ml benzene 
0.168 g in 20 ml benzene 
82% ethylene 
Polysciences cat. #02309 
Aldrich 
Arc Mw 100000 
0.162 g in benzene 
*Sonicated each suspension for 5 min. 
Aldrich [25067-59-31 
18,260-5 
Ave. Mw CQ 1,100,000 
0.162 g polymer 
16. Poly(ethy1ene - vinyl acetate) [24937-78-81 39 mg carbon black 
17. Poly(ethy1eneoxide) [25322-68-31 42 mg carbon black 
18. Poly(9-vinyl carbazole) -40 mg carbon black 
It is understood that the examples and embodiments peviodonticum, Pvevotella melaninogenica, Klebsiella 
described herein are for illustrative purposes only and that 25 pneumoniae, Entevobactev cloacae, Citrobacter species and 
various modifications or changes in light thereof will be Stomatococcus mucilaginus. 
suggested to persons skilled in the art and are to be included 5 .  The method of claim 1, wherein said array of S e m m  
within the spirit and purview of this application and scope of comprises a member selected from the P U P  consisting of 
the appended claims. All publications, patents, and patent a surface acoustic wave 
ence for all purposes in their entirety. 
a quartz 
applications cited herein are hereby incorporated by refer- sensor, a conductive composite; a chemiresistor; a metal 
30 oxide gas sensor and a conducting polymer sensor, a dye- 
impregnated polymer film on fiber optic detector, a polymer- 
coated micromirror, an electrochemical gas detector, a 
chemically sensitive field-effect transistor, a carbon black- 
polymer composite, a micro-electro-mechanical system 
device and a micro-opto-electro-mechanical system device. 
What is claimed is: 
1, A method for the analyte profiles of mam- 
malian breath samples for diagnosing and monitoring a 
medical condition, said method comprising: 
contacting an array Of with a first Of 35 6, The method of claim 1, further comprising generating 
a response from said Sensors and inputting said response to breath to identify analytes in said first 
sample; and 
(b) storing the results of the analysis of said first sample 
in a computer-readable format; 
(c) contacting an array of sensors with a second sample of 40 
mammalian breath to identify analytes in said second 
sample; and mammalian breath; 
(d) comparing the results of said second sample with the 
stored results of the analysis of said first sample, 45 
thereby comparing the analyte profiles of mammalian 
breath samples, wherein the comparison of the analyte 
profiles are used to diagnose and monitor a medical 
condition. 
2. The method of claim 1, wherein said analyte is a marker 50 
gas. 
3. The method of claim 2, wherein said marker gas is a 
member selected from the group consisting of alkanes, 
alkenes, alkynes, dienes, alicyclic hydrocarbons, arenes, 
alcohols, ethers, ketones, aldehydes, carbonyls, carbanions, 55 
polynuclear aromatics, biomolecules, sugars, isoprenes 
identify analytes in said second sample; and pyridines, picolines, an off-gas of a microorganism and fatty 
acids. (h) comparing the results of the analysis of said first and 
4. The method of claim 3, wherein said marker gas is an second breath samples, wherein the comparison of the 
off gas of a member selected from the group consisting of 60 results of the analysis are used to diagnose and monitor 
Pvevotella intevmedia, Fusobacterium nucleatum, Povphy- a medical condition. 
vomonas gingivalis, Povphyvomonas endodontalis, Pvevo- 8. The method of claim 1 or 7, wherein the comparing the 
tella loescheii, Hemophilus pavainfuenzae, Stomatococcus 
muci, Treponema denticola, Veillonella species, Peptostvep- 9. The method of claim 1 or 7, wherein the comparing the 
tococcus anaevobius, Micros pvevotii, Eubacterium 65 results is diagnostic of an upper respiratory tract infection. 
limosum, Centipeda peviodontii, Selemonad avemidis, 
a neural net trained against known marker gases. 
7. A method for comparing the analyte profiles of mam- 
malian breath samples for diagnosing and monitoring a 
(a) contacting an array of Sensors with first sample of 
(b) detecting a first set Of from said Of 
sensors, wherein said set of responses is a first sensor 
array response profile; 
(C) analyzing said first Sensor array response Profile to 
identify analytes in said first sample; 
(d) storing said first sensor array response profile and the 
results of the analysis; 
(e) contacting an array of sensors with a second sample of 
mammalian breath; 
( f )  detecting a second set of responses from said array of 
sensors, wherein said set of responses is a second 
condition said method comprising: 
array response profile; 
isoprenoids, VOC, VOA, indoles, skatoles, diamines, (g) said second array response profile to 
results is diagnostic of a lower respiratory tract infection. 
Eubacterium species, Bacteriodes species, Fusobacterium * * * * *  
